Reply to: "Beyond BMI in interpreting sex-specific blood pressure trajectories: a comment on Kawasoe et al." [1] [0.03%]
关于Kawasoe等人的评论“超越BMI以解读性别特异性血压轨迹”[1]的回信
Shin Kawasoe,Takuro Kubozono,Yuichi Akasaki et al.
Shin Kawasoe et al.
The blood pressure-lowering effect of an anti-soluble epoxide hydrolase vaccine in angiotensin II-induced hypertension in mice [0.03%]
一种抗可溶性环氧合酶水解酶疫苗的降血压作用：ANG II诱导的小鼠高血压模型中的作用研究
Shigeki Shichida,Yuya Takahashi,Aya Shiraki et al.
Shigeki Shichida et al.
We developed a soluble epoxide hydrolase (sEH) vaccine as a novel therapeutic strategy against hypertension. A placebo-controlled study was conducted to investigate its efficacy. Fifty-five wild-type mice were randomly divided into three gr...
Author's reply to the letter to the editor entitled "Comment on: Predictive value of high-density lipoprotein cholesterol and the cardio-ankle vascular index on cardiovascular outcomes in subjects with cardiovascular risks: the COUPLING study" [0.03%]
作者对题为“评论：高密度脂蛋白胆固醇和心血管风险受试者的心血管预后指标的预测价值：来自COUPLING研究的证据”的信函回复
Tomoyuki Kabutoya,Kazuomi Kario
Tomoyuki Kabutoya
Response to the correspondence by Dr. Liu: Comment on "The effects of glucagon-like peptide-1 receptor agonists on sympathetic neuron activity" [0.03%]
刘医生关于“胰高血糖素样肽-1受体激动剂对交感神经活性影响”的来信答复
Yui Koyanagi,Kamon Iigaya,Keiko Ikeda et al.
Yui Koyanagi et al.
Influence of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on the management of blood pressure in Japanese patients with diabetes [0.03%]
钠葡萄糖协同转运蛋白2抑制剂与胰高血糖素样肽1受体激动剂联合治疗对日本糖尿病患者血压管理的影响
Takaya Matsushita,Yukihiro Wada,Masuo Saburi et al.
Takaya Matsushita et al.
Combination therapy with a sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) is increasingly used to prevent cardiovascular events. Our previous study demonstrated the renal benefits of...
Prevalence, trends, and subtype-specific outcomes of hypertensive disorders in pregnancy in China: data from 18 million pregnant women in a hospitalization-based retrospective study [0.03%]
中国妊娠期高血压疾病的患病率、趋势及亚型特异性结局：基于1800万例住院孕妇的回顾性研究数据
Lian Chen,Huifeng Shi,Yuan Wei et al.
Lian Chen et al.
Evidence on subtype-specific risks of adverse outcomes associated with hypertensive disorders of pregnancy (HDP) remains limited. This study aimed to analyze temporal trends in HDP prevalence and investigate subtype-specific associations wi...
Response to: "Distinct associations of blood pressure phenotypes with subclinical cerebrovascular disease and coronary artery calcification in Japanese men" [0.03%]
对“血压表型与日本人男性亚临床脑血管疾病和冠状动脉钙化的关系”的回复
Nomin Bayaraa,Yuichiro Yano,Aya Kadota et al.
Nomin Bayaraa et al.